borderline significanceP = 0.05
There was a borderline significance of higher prevalence ( P = 0.05) of loss of PTEN expression in elderly patients (age≥65 years) (54.0%) than in younger patients (37.4%).
There was a borderline significance of higher prevalence ( P = 0.05) of loss of PTEN expression in elderly patients (age≥65 years) (54.0%) than in younger patients (37.4%).